파로스백신

본문 바로가기
사이트 내 전체검색

파로스백신

ip

Patents

The chimeric protein immunogen manufacturing technology, which is the core technology of foot-and-mouth disease recombinant protein vaccine with excellent immunogenic capabilities using our platform technology of protein engineering, has been registered for a patent in 13 countries worldwide including Korea.

Patent Registration Status

Country Patent Number Designation Registration Date State
EU(EP) 09821602.1

A vaccine composition against foot-and-mouth disease and the preparation method thereof

2017-03-03 Enrollment
Vietnam 15506

A vaccine composition against foot-and-mouth disease and the preparation method thereof

2016-05-16 Enrollment
Philippines 1-2011-500792

A vaccine composition against foot-and-mouth disease and the preparation method thereof

2016-01-14 Enrollment
Canada 2741419

Anti-FMD vaccine composition and the preparation and use thereof

2015-01-27 Enrollment
Hong Kong HK1144787

Anti-FMD Vaccine Composition and Preparation and Use Thereof

2014-11-14 Enrollment
Japan 5565877

Anti-FMD vaccine composition and preparation and use thereof

2014-06-27 Enrollment
USA 8,551,495

ANTI-FMD VACCINE COMPOSITION AND THE PREPARATION AND USE THEREOF

2013-10-08 Enrollment
Republic of Korea 10-1313159

Foot and mouth disease vaccine composition and preparation method thereof

2013-09-24 Enrollment
Australia 2009306900

A vaccine composition against foot-and-mouth disease and the preparation method thereof

2013-09-19 Enrollment
  • AU-2009306900 특허등록증

    AU-2009306900

  • CN-ZL200810172927.8 특허등록증

    CN-ZL200810172927

  • EP-2351581 특허증

    EP-2351581

  • JP-5565877 특허등록증

    JP-5565877

  • PH_1-2011-500792 특허등록증

    PH_1-2011-500792

  • Turkey_PAT Certificate

    Turkey_PAT

  • US-8,551,495 특허등록증

    US-8,551,495

  • VN_15506 특허등록증

    VN_15506

New Excellent Technology Certificate

The foot-and-mouth disease recombinant protein vaccine technology of Pharos Vaccine has obtained New Excellent Technology (NET) certificate from the Ministry of Trade, Industry and Energy and Ministry of Agriculture, Food and Rural Affairs after thorough verification procedures by the Korean government.

Certification Certification Number Technical Name Certification Date
Ministry of Agriculture, Food and Rural Affairs No. 23-057

Recombinant protein and foot-and-mouth disease bivalent composition manufacturing technology

2018-07-05
Ministry of Trade, Industry and Energy No. 0948

Manufacturing technology of foot and mouth vaccine composition using VP1 repeat recombinant protein

2015-08-27
  • NET 신기술인증서 농식품부 국문

    NET New Technology Certificate Ministry of Agriculture and Food (Korean)

  • NET 신기술인증서 농식품부(영문)

    NET New Technology Certificate Ministry of Agriculture and Food (English)

ANIMAL MEDICINE APPROVAL

Pharos Vaccine’s foot-and-mouth disease recombinant protein vaccine PharoVax-FMD has been validated for its safety and efficacy with a field clinical trial and virus challenge test, and is the first to obtain an animal medicine approval for foot-and-mouth disease vaccine in Korea. This is the first approval in the world of an FMD vaccine using recombinant protein as the immunogen, and Pharos Vaccine is not only promoting the product domestically, but is also exporting our FMD vaccine technology and products to foreign countries including China and Vietnam based on our excellent technology.

  • 제조품목허가증

    PharoVax-FMD approval certificate

회원로그인

접속자집계

오늘
355
어제
2,082
최대
3,999
전체
463,292

그누보드5
Copyright © 소유하신 도메인. All rights reserved.